- PAMELA JOHNSON
- CASSANDRA LYTLE STEINKE
- MELISSA SCHROEDER
One hour didactic session where speakers deliver clinical, basic science and translational talks on neurology and neuroscience related topics. Speakers include UW neurology department faculty members, including neuropsychologists, researchers, clinical faculty, neurology residents, as well as other UW clinicians/researchers or invited speakers from outside UW.
MD, medical students, PhD (faculty, post-docs) graduate students, Researchers and Scientists, MDPhDs, DO, NPs, PAs, RN, APRN, Psychologists, Faculty and resident specialties including neurology (adult and pediatric neurology, neuropsychology), neurosurgery, neuroradiology, interventional neuroradiology, developmental pediatrics
|Teresa Mangin, MD, Chair
|Jenny Broihan Becker
|Mihaela Bazalakova, MD
|Pamela Johnson, Coordinator
|Corinna Burger, PhD
|Cassandra Lytle Steinke
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
As a result of participation in this educational activity, learners will be able to:
- Enhance their comprehensive knowledge of clinical guidelines for evidence-based neurological patient care.
- Evaluate neuroscience research that they may implement in their clinical or research practice.
- Apply knowledge of the scientific method to research and scholarly practice in the fileds of neuroscience and clinical neurology.